7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2013-12-31 2013-09-30 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2007-12-31 2007-09-30 2007-08-06 
      
    		                                                               
      revenue:
    		                                                               
      product revenue
    		159,317,000 138,843,000 119,655,000 107,347,000 83,297,000 72,596,000 50,488,000 43,137,000 25,068,000 16,036,000 7,765,000 647,750 56,000 556,000 1,978,000 2,283,000 1,992,000 1,507,000 755,000                                             
      license, milestone, royalty and other revenue
    		2,392,000 2,305,000 1,201,000 838,000 582,000 870,000 12,986,000                                                         
      total revenue
    		161,709,000 141,148,000 120,856,000 108,185,000 83,879,000 73,466,000 63,474,000 43,971,000 165,815,000 16,074,000 7,803,000 676,250 94,000 594,000 2,016,000 1,092,000 2,030,000 1,545,000 793,000                                             
      yoy
    		92.79% 92.13% 90.40% 146.04% -49.41% 357.05% 713.46% 6402.18% 176298.94% 2606.06% 287.05% -38.07% -95.37% -61.55% 154.22%                                                 
      qoq
    		14.57% 16.79% 11.71% 28.98% 14.17% 15.74% 44.35% -73.48% 931.57% 106.00% 1053.86% 619.41% -84.18% -70.54% 84.62% -46.21% 31.39% 94.83%                                              
      costs and expenses:
    		                                                               
      cost of revenue
    		28,093,000 18,938,000 15,541,000 15,399,000 9,341,000 8,304,000 5,441,000 7,854,000 3,509,000                                                       
      gross profit
    		133,616,000 122,210,000 105,315,000 92,786,000 74,538,000 65,162,000 58,033,000 36,117,000 162,306,000                                                       
      yoy
    		79.26% 87.55% 81.47% 156.90% -54.08%                                                           
      qoq
    		9.33% 16.04% 13.50% 24.48% 14.39% 12.28% 60.68% -77.75%                                                        
      gross margin %
    		82.63% 86.58% 87.14% 85.77% 88.86% 88.70% 91.43% 82.14% 97.88% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%                                             
      research and development:
    		                                                               
      noncash compensation
    		5,335,000 4,318,000 3,331,000 3,160,000 3,028,000 2,520,000 2,452,000 2,848,000 2,915,000 5,664,000 1,584,000 5,753,000 3,249,000 2,328,000 1,895,000 4,986,000 4,534,000 7,016,000 7,511,000 5,812,000 4,618,000 1,553,000 1,979,000 1,488,000 1,482,000 1,352,000 1,489,000 1,207,000 644,000 888,000 2,859,000 260,007 1,814,288 1,266,322 2,306,099 868,624 919,648 567,157 386,925 1,528,296 35,756 1,359,446 1,337,908 2,329,270 1,200,575 3,300,111 149,206 171,442                
      other research and development
    		35,543,000 27,464,000 43,031,000 20,714,000 17,110,000 15,036,000 30,270,000 14,601,000 11,838,000 22,458,000 14,286,000 23,882,000 17,552,000 24,546,000 46,147,000 57,660,000 47,433,000 37,855,000 55,583,000 37,149,000 45,846,000 34,896,000 34,043,000 29,455,000 56,503,000 31,414,000 30,896,000 51,069,000 32,754,000 34,812,000 32,159,000 25,736,101 25,334,762 25,439,477 20,375,794 21,414,723 20,878,108 12,966,574 11,230,415 13,725,926 11,538,246 9,902,214 8,279,431 12,807,504 8,352,154 2,336,771 3,606,385 3,138,119                
      total research and development
    		40,878,000 31,782,000 46,362,000 23,874,000 20,138,000 17,556,000 32,722,000 17,449,000 14,753,000 28,122,000 15,870,000 29,635,000 20,801,000 26,874,000 48,042,000 62,646,000 51,967,000 44,871,000 63,094,000 42,961,000 50,464,000 36,449,000 36,022,000 30,943,000 57,985,000 32,866,000 32,385,000 52,276,000 33,398,000 38,700,000 35,018,000 25,996,108 27,149,050 26,705,799 22,681,893 22,283,347 21,797,756 13,533,731 11,617,340 15,254,222 11,574,002 11,261,660 9,617,339 15,136,774 13,691,573 6,848,132 3,755,591 3,309,561                
      selling, general and administrative:
    		                                                               
      other selling, general and administrative
    		51,022,000 43,541,000 38,691,000 30,175,000 33,221,000 31,828,000 27,694,000 24,616,000 26,500,000 23,838,000 22,828,000 17,206,000 10,514,000 15,942,000 20,383,000 23,042,000 25,436,000 24,729,000 17,655,000                                             
      total selling, general and administrative
    		63,373,000 55,585,000 50,331,000 38,963,000 41,966,000 38,790,000 34,581,000 31,153,000 32,769,000 30,715,000 28,068,000 22,504,000 14,254,000 12,638,000 20,609,000 32,412,000 34,899,000 34,017,000 26,762,000                                             
      total costs and expenses
    		132,344,000 106,305,000 112,234,000 78,236,000 71,445,000 64,650,000 72,744,000 56,456,000 51,031,000 60,748,000 44,795,000 52,142,000 35,057,000 39,535,000 68,888,000 95,268,000 87,158,000 79,036,000 89,995,000 86,820,000 85,760,000 50,883,000 50,283,000 37,999,000 60,899,000 35,582,000 34,727,000 54,188,000 34,366,000 44,383,000 40,615,000 31,072,826 31,623,323 28,463,466 27,704,517 24,066,153 24,963,567 16,061,538 14,030,251 17,678,096 13,863,680 17,149,675 14,640,946 18,759,219 17,477,442 11,993,592 8,013,861 4,685,513                
      operating income
    		29,365,000 34,843,000 8,622,000 29,949,000 12,434,000 8,816,000 -9,270,000 -12,485,000 114,784,000 -44,674,000 -36,992,000 -52,062,000 -34,963,000 -38,941,000 -66,872,000 -92,947,000 -85,128,000 -77,492,000 -89,202,000 -86,782,000 -85,722,000 -50,845,000 -50,245,000 -37,961,000 -60,861,000 -35,544,000 -34,689,000 -54,150,000 -34,328,000 -44,345,000 -41,577,000 -31,034,731 -31,585,227 -28,425,371 -27,666,422 -24,028,058 -24,925,471 -16,023,443 -13,992,156 -17,640,001 -13,825,584 -17,111,580 -14,602,851 -18,721,124 -17,439,346 -11,955,497 -7,975,766 -4,647,417 -261,843 -322,906 -566,085 -61,322,150 -515,631 -525,091 -529,445 -59,445,344 -395,640 -477,260 -557,336  -44,466,120 -2,707,021 -45,141,536 
      yoy
    		136.17% 295.22% -193.01% -339.88% -89.17% -119.73% -74.94% -76.02% -428.30% 14.72% -44.68% -43.99% -58.93% -49.75% -25.03% 7.10% -0.69% 52.41% 77.53% 128.61% 40.85% 43.05% 44.84% -29.90% 77.29% -19.85% -16.57% 74.48% 8.68% 56.00% 50.28% 29.16% 26.72% 77.40% 97.73% 36.21% 80.29% -6.36% -4.18% -5.77% -20.72% 43.13% 83.09% 302.83% 6560.23% 3602.47% 1308.93% -92.42% -49.22% -38.50% 6.92% 3.16% 30.33% 10.02% -5.00%  -99.11% -82.37% -98.77%     
      qoq
    		-15.72% 304.12% -71.21% 140.86% 41.04% -195.10% -25.75% -110.88% -356.94% 20.77% -28.95% 48.91% -10.22% -41.77% -28.05% 9.18% 9.85% -13.13% 2.79% 1.24% 68.59% 1.19% 32.36% -37.63% 71.23% 2.46% -35.94% 57.74% -22.59% 6.66% 33.97% -1.74% 11.12% 2.74% 15.14% -3.60% 55.56% 14.52% -20.68% 27.59% -19.20% 17.18% -22.00% 7.35% 45.87% 49.90% 71.62% 1674.89% -18.91% -42.96% -99.08% 11792.64% -1.80% -0.82% -99.11% 14925.11% -17.10% -14.37%   1542.62% -94.00%  
      operating margin %
    		18.16% 24.69% 7.13% 27.68% 14.82% 12.00% -14.60% -28.39% 69.22% -277.93% -474.07% -7698.63% -37194.68% -6555.72% -3317.06% -8511.63% -4193.50% -5015.66% -11248.68%                                             
      other income:
    		                                                               
      interest expense
    		6,721,000 6,716,000 6,757,000 7,061,000 10,832,000 3,977,000 2,288,000 2,431,000 3,713,000 3,627,000 2,844,000 2,862,000 1,648,000 3,017,000 2,664,000 1,079,000 1,038,000 1,623,000 1,898,000 1,291,000 1,610,000 2,228,000 1,201,000 1,899,000 1,537,000 1,077,000          168,674.75 211,538 220,756 242,405 242,026 246,527 246,526 237,657 234,787 234,787 234,787 178,004 240,530 1,165,078 428,210 289,598 234,388.75 349,562 351,215 236,777 99,174.5 136,738 134,510 125,450  25,559  26,033 
      other income
    		-3,265,000 -2,793,000 -3,603,000 -2,565,000 -2,666,000 -1,712,000 -880,000 -890,000 -2,859,000 -691,000 -604,000 -1,930,000 -793,000 -1,448,000 -523,000 -688,000 -529,000 -618,000 -472,000 145,000 -169,000 -189,000 -330,000 -288,000 -468,000 -408,000 616,000 -24,000 -119,000 -14,000 96,000   -22,090 105,783 -360,160 -33,042                           
      total other income
    		3,456,000 3,923,000 3,154,000 4,496,000 8,166,000 2,265,000 1,408,000 1,541,000 854,000 2,936,000 2,240,000 932,000 855,000 1,569,000 2,141,000 391,000 509,000 1,005,000 1,426,000 1,436,000 1,441,000 2,039,000 871,000 1,611,000 1,069,000 669,000 467,000 -290,000 -377,000 -203,000 -48,000 -174,964 -49,575 -72,287 61,087 -353,915 -94,444 -124,381 -143,494 -28,189 -169,668 -8,397 -25,116 75,305 11,823 30,933 -43,966.25 -91,222 289,896 2,659,633 -4,398,468 -933,591 -556,878 -2,375,427 1,103,724 -1,261,926 20,449 915,177 204,508  -774,772 -37,600 -790,105 
      net income before taxes
    		25,909,000 30,920,000 5,468,000 25,453,000 4,268,000 6,551,000 -10,678,000                                                         
      income tax benefit
    		364,986,000 -2,733,000    328,000                                                          
      net income
    		390,895,000 28,187,000 5,060,000 23,331,000 3,880,000 6,879,000 -10,707,000 -14,416,000 113,930,000 -47,610,000 -39,232,000 -52,994,000 -35,818,000 -40,510,000 -69,013,000 -93,338,000 -85,637,000 -78,497,000 -90,628,000 -88,218,000 -87,163,000 -52,884,000 -51,116,000 -39,572,000 -61,930,000 -36,213,000 -35,156,000 -53,860,000 -33,951,000 -44,142,000 -41,529,000 -30,859,767 -31,535,652 -28,353,084 -27,727,509 -13,644,687.75 -24,831,027 -15,899,062 -13,848,662 -17,611,812 -13,655,916 -17,103,183 -14,577,735      -551,739 -2,982,539 3,832,383 -60,388,559 41,247 1,850,336 -1,633,169 -58,183,418 -416,089 -1,392,437 -761,844  -43,691,348 -2,669,421 -44,351,431 
      yoy
    		9974.61% 309.75% -147.26% -261.84% -96.59% -114.45% -72.71% -72.80% -418.08% 17.53% -43.15% -43.22% -58.17% -48.39% -23.85% 5.80% -1.75% 48.43% 77.30% 122.93% 40.74% 46.04% 45.40% -26.53% 82.41% -17.96% -15.35% 74.53% 7.66% 55.69% 49.78% 126.17% 27.00% 78.33% 100.22% -22.53% 81.83% -7.04% -5.00%          -1437.65% -261.19% -334.66% 3.79% -109.91% -232.88% 114.37%  -99.05% -47.84% -98.28%     
      qoq
    		1286.79% 457.06% -78.31% 501.31% -43.60% -164.25% -25.73% -112.65% -339.30% 21.36% -25.97% 47.95% -11.58% -41.30% -26.06% 8.99% 9.10% -13.39% 2.73% 1.21% 64.82% 3.46% 29.17% -36.10% 71.02% 3.01% -34.73% 58.64% -23.09% 6.29% 34.57% -2.14% 11.22% 2.26% 103.21% -45.05% 56.18% 14.81% -21.37% 28.97% -20.16% 17.32%       -81.50% -177.82% -106.35% -146507.15% -97.77% -213.30% -97.19% 13883.41% -70.12% 82.77%   1536.74% -93.98%  
      net income margin %
    		241.73% 19.97% 4.19% 21.57% 4.63% 9.36% -16.87% -32.79% 68.71% -296.19% -502.78% -7836.45% -38104.26% -6819.87% -3423.26% -8547.44% -4218.57% -5080.71% -11428.50%                                             
      net income per common share:
    		                                                               
      basic
    		2,690 190 30 160 30 50  -100 800                                                       
      diluted
    		2,430 170 30 150 20 40  -100 730                                                       
      weighted-average shares of common stock outstanding
    		                                                               
      basic
    		145,416,901,000 146,739,833,000 146,677,783,000 145,317,418,000 145,102,479,000 144,727,482,000  141,955,112,000 142,871,227,000                                                       
      diluted
    		160,997,977,000 162,559,404,000 162,769,202,000 160,336,051,000 160,714,388,000 159,423,571,000  148,508,465,000 155,871,749,000                                                       
      ​
    		                                                               
      income tax expense
    		  408,000 22,250 388,000                                                           
      income taxes
    		      29,000                                                         
      basic and diluted net income per common share
    		      -70   -340 -280 -380 -260 -300 -510 -700 -650 -590 -690 -720 -730 -470 -480 -410 -690 -420 -430 -690 -430 -590 -590 -0.46 -0.48 -0.45 -0.52 -0.49 -0.5 -0.33 -0.28 -0.37 -0.28 -0.38 -0.35 -0.5 -0.51 -0.36 -0.155 -0.16                
      weighted-average shares used for eps calculation
    		      146,209,213,000   141,503,738,000 140,312,269,000 135,411,258,000 135,327,035,000 134,779,904,000 134,400,500,000 132,222,753,000 132,353,119,000 132,072,996,000 131,898,626,000 115,333,693,000 119,176,336,000 112,353,414,000 105,461,892,000 88,368,844,000 89,667,979,000 86,800,017,000 81,174,301,000  78,221,069,000 74,256,348,000 70,636,970,000  65,079,128 63,288,269 53,157,851  49,203,277 48,769,948 48,908,278 45,646,414 47,946,309 45,320,637 41,088,752 34,068,926 34,188,108 32,985,130  27,684,802                
      license, milestone and other revenue
    		       834,000 140,747,000                                                       
      weighted-average shares outstanding:
    		                                                               
      basic
    		145,416,901,000 146,739,833,000 146,677,783,000 145,317,418,000 145,102,479,000 144,727,482,000  141,955,112,000 142,871,227,000                                                       
      diluted
    		160,997,977,000 162,559,404,000 162,769,202,000 160,336,051,000 160,714,388,000 159,423,571,000  148,508,465,000 155,871,749,000                                                       
      license revenue
    		                   38,000 38,000 38,000 38,000 38,000 38,000 38,000 38,000 38,000 38,000 38,000 38,000 38,095 38,096 38,095 38,095 38,095 38,096 38,095 38,095 38,095 38,096 38,095 38,095 38,095 38,096 38,095 38,095 38,096                
      cost of product revenue
    		                                                               
      noncash stock expense associated with in-licensing agreements
    		                                                               
      general and administrative:
    		                                                               
      other general and administrative
    		                   16,150,000 11,584,000 8,617,000 5,172,000 2,924,000 2,321,000 2,311,000 1,949,000 1,661,000 1,785,000 2,308,000 2,119,000 1,766,747 1,398,438 1,534,261 1,333,268 1,322,831 1,251,421 1,446,567 1,100,871 1,095,126 1,085,400 1,004,475 1,004,487 913,279 889,872 706,725 662,728 550,639                
      total general and administrative
    		                   43,859,000 35,296,000 14,434,000 14,261,000 7,056,000 2,914,000 2,716,000 2,342,000 1,912,000 968,000 5,683,000 6,597,000 5,076,718 4,474,273 1,757,667 5,022,624 1,782,806 3,165,811 2,527,807 2,412,911 2,423,874 2,289,678 5,888,015 5,023,607 3,622,445 3,785,869 5,145,460 1,460,670 1,375,952                
      other income :
    		                                                               
      noncash stock expense associated with in–licensing agreements
    		                       25,000                                        
      non-cash stock expense associated with in–licensing agreements
    		                         100,000  1,000,000  3,000,000                                  
      interest income
    		                          -149,000 -266,000 -258,000 -189,000 -144,000 -120,422 -79,163 -50,197 -44,696 -57,576 -87,965 -92,629 -84,862 -64,993 -55,977 -31,551 -22,132 -16,741 -12,107 -12,727 -3,763.5 -12,375                
      other
    		                               28,320.25 29,588                               
      change in fair value of notes payable
    		                                   -184,630 -184,975 -252,508 -301,037 -205,222 -360,218 -223,372 -240,641 -142,741 -210,857 -191,127 -218,206.75 -319,377                
      noncash stock expense associated with in-licensing agreement
    		                                             1,211,250                  
      noncash stock expense associated with in- licensing agreements
    		                                           1,337,523.5 4,138,844                   
      consolidated net income
    		                                           -9,246,212 -17,451,169 -11,986,430 -5,663,852 -4,556,195                
      impairment of in-process research and development
    		                                                               
      income before income taxes
    		                                              -5,663,852 -4,556,195                
      net income attributable to noncontrolling interest
    		                                                               
      net income attributable to tg therapeutics, inc. and subsidiaries
    		                                              -3,703,589.5 -4,556,195                
      revenue
    		                                                               
      research and development
    		                                                95,897 90,218 355,177 28,522,504 236,734 50,999 17,767 28,275,057 5,574 6,644 44,936  19,129,003 1,808,958  
      general and administrative
    		                                                165,946 232,688 210,908 18,449,731 278,897 474,092 511,678 16,820,372 390,066 470,616 512,400  10,987,202 898,063  
      in-process research and development charge
    		                                                              11,887,807 
      impairment of intangible assets
    		                                                              1,248,230 
      loss on disposition of intangible assets
    		                                                              1,213,878 
      total operating expenses
    		                                                261,843 322,906 566,085 61,322,150 515,631 525,091 529,445 59,445,344 395,640 477,260 557,336  44,466,120 2,707,021 45,141,536 
      equity in losses of hedrin jv
    		                                                       412,952 105,362 95,900 135,786     
      change in fair value of derivative liability
    		                                                -2,100,898 2,231,746 -170,435 -674,225 -830,165           
      interest and other income
    		                                                -196 -323 -143 -2,187,369 -76,275 -76,716 -75,314 -1,614,729 -63,873 -61,900 -126,728  -724,299 -37,600 -740,106 
      loss on early extinguishment of debt
    		                                                1,225,912     159,070          
      realized gain on sale of marketable equity securities
    		                                                              -76,032 
      preferred stock dividends
    		                                                              -1,179,644 
      net income applicable to common shares
    		                                                -551,739 -2,982,539 3,832,383 -61,568,204 41,247 1,850,336 -1,633,169 -59,363,063 -416,089 -1,392,437 -761,844  -44,870,992 -2,669,421 -45,531,075 
      net income per common share:
    		                                                               
      basic and diluted
    		                                                -0.16 -1.15 0.03  0 0.02 -0.02 -0.01 -0.01 -0.02 -0.01  -0.038 -0.04  
      weighted-average shares of common stock outstanding:
    		                                                               
      basic and diluted
    		                                                3,431,031 2,595,866 127,439,132  120,965,244 120,429,688 84,638,502  70,624,232 70,624,232 70,624,232   70,591,623  
      gain on nordic settlement
    		                                                  -4,517,488             
      change in fair value of derivative
    		                                                     -2,808,996 942,261 -228,819 -157,778 746,667 70,000     
      (including stock based compensation expense of
    		                                                               
      102,739, 98,302 and 631,462 for the three months
    		                                                               
      ended march 31, 2007, march 31, 2006 and for the
    		                                                               
      cumulative period from august 6, 2001 (inception) to
    		                                                               
      march 31, 2007, respectively)
    		                                                              19,632,804 
      232,471, 213,610 and 1,379,247 for the three months
    		                                                               
      see accompanying notes to unaudited condensed consolidated financial statements.
    		                                                               
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.